A chemokine self-presentation mechanism involving formation of endothelial surface microstructures

Journal of Immunology

Volumn 190, Issue 4, 2013, Pages 1725-1736

  Whittall, Catherine ^a   Kehoe, Oksana ^a   King, Sophie ^b   Rot, Antal ^c   Patterson, Angela ^d   Middleton, Jim ^a,b  

^a KEELE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DUFFY ANTIGEN RECEPTOR FOR CHEMOKINE; EPITOPE; FASCIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; INTERLEUKIN 8; PEPTIDES AND PROTEINS; RAB7 PROTEIN; RANTES; SCLEROPROTEIN; SYNDECAN 3; SYNDECAN 4; TROPOMYOSIN; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ARTICLE; BONE MARROW ENDOTHELIAL CELL; CELL INTERACTION; CELL STRUCTURE; CELL SURFACE; CONTROLLED STUDY; CYTOSKELETON; ENDOTHELIUM CELL; FILOPODIA LIKE PROTRUSION; HUMAN; HUMAN CELL; LEUKOCYTE MIGRATION; MASS SPECTROMETRY; MICROVASCULAR ENDOTHELIAL CELL; MICROVILLUS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; UMBILICAL VEIN ENDOTHELIAL CELL;

ANTIGEN-PRESENTING CELLS; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELLS, CULTURED; CHEMOKINE CCL5; CHEMOKINE CXCL10; ENDOTHELIUM, VASCULAR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-8; LEUKOCYTES; MICROCIRCULATION; SURFACE PROPERTIES; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

EID: 84873545229     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200867     Document Type: Article

References (39)

1. Middleton, J., L. Americh, R. Gayon, D. Julien, L. Aguilar, F. Amalric, and J. P. Girard. 2004. Endothelial cell phenotypes in the rheumatoid synovium: activated, angiogenic, apoptotic and leaky. Arthritis Res. Ther. 6: 60-72.
2. De Smet, F., I. Segura, K. De Bock, P. J. Hohensinner, and P. Carmeliet. 2009. Mechanisms of vessel branching: filopodia on endothelial tip cells lead the way. Arterioscler. Thromb. Vasc. Biol. 29: 639-649.
3. Petrovic, N., W. Schacke, J. R. Gahagan, C. A. O'Conor, B. Winnicka, R. E. Conway, P. Mina-Osorio, and L. H. Shapiro. 2007. CD13/APN regulates endothelial invasion and filopodia formation. Blood 110: 142-150.
4. Sainson, R. C., D. A. Johnston, H. C. Chu, M. T. Holderfield, M. N. Nakatsu, S. P. Crampton, J. Davis, E. Conn, and C. C. Hughes. 2008. TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype. Blood 111: 4997-5007.
5. Sattar, A., P. Kumar, and S. Kumar. 1986. Rheumatoid- and osteo-arthritis: quantitation of ultrastructural features of capillary endothelial cells. J. Pathol. 148: 45-53.
6. Walski, M., S. Chlopicki, R. Celary-Walska, and M. Frontczak-Baniewicz. 2002. Ultrastructural alterations of endothelium covering advanced atherosclerotic plaque in human carotid artery visualised by scanning electron microscope. J. Physiol. Pharmacol. 53: 713-723.
7. Lossinsky, A. S., R. Pluta, M. J. Song, V. Badmajew, R. C. Moretz, and H. M. Wisniewski. 1991. Mechanisms of inflammatory cell attachment in chronic relapsing experimental allergic encephalomyelitis: a scanning and high-voltage electron microscopic study of the injured mouse blood-brain barrier. Microvasc. Res. 41: 299-310.
8. Swensson, O., C. Schubert, E. Christophers, and J. M. Schröder. 1991. Inflammatory properties of neutrophil-activating protein-1/interleukin 8 (NAP-1/IL-8) in human skin: a light- and electronmicroscopic study. J. Invest. Dermatol. 96: 682-689.
9. Middleton, J., S. Neil, J. Wintle, I. Clark-Lewis, H. Moore, C. Lam, M. Auer, E. Hub, and A. Rot. 1997. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 91: 385-395.
10. Pruenster, M., L. Mudde, P. Bombosi, S. Dimitrova, M. Zsak, J. Middleton, A. Richmond, G. J. Graham, S. Segerer, R. J. Nibbs, and A. Rot. 2009. The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat. Immunol. 10: 101-108.
11. Feng, D., J. A. Nagy, K. Pyne, H. F. Dvorak, and A. M. Dvorak. 1998. Neutrophils emigrate from venules by a transendothelial cell pathway in response to FMLP. J. Exp. Med. 187: 903-915.
12. Carman, C. V., P. T. Sage, T. E. Sciuto, M. A. de la Fuente, R. S. Geha, H. D. Ochs, H. F. Dvorak, A. M. Dvorak, and T. A. Springer. 2007. Transcellular diapedesis is initiated by invasive podosomes. Immunity 26: 784-797.
13. Carman, C. V., C. D. Jun, A. Salas, and T. A. Springer. 2003. Endothelial cells proactively form microvilli-like membrane projections upon intercellular adhesion molecule 1 engagement of leukocyte LFA-1. J. Immunol. 171: 6135-6144.
14. Carman, C. V., and T. A. Springer. 2004. A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them. J. Cell Biol. 167: 377-388.
15. Schweitzer, K. M., P. Vicart, C. Delouis, D. Paulin, A. M. Dräger, M. M. Langenhuijsen, and B. B. Weksler. 1997. Characterization of a newly established human bone marrow endothelial cell line: distinct adhesive properties for hematopoietic progenitors compared with human umbilical vein endothelial cells. Lab. Invest. 76: 25-36.
16. Dennissen, M. A., G. J. Jenniskens, M. Pieffers, E. M. Versteeg, M. Petitou, J. H. Veerkamp, and T. H. van Kuppevelt. 2002. Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies. J. Biol. Chem. 277: 10982-10986.
17. van Kuppevelt, T. H., M. A. Dennissen, W. J. van Venrooij, R. M. Hoet, and J. H. Veerkamp. 1998. Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney. J. Biol. Chem. 273: 12960-12966.
18. Smith, W. B., J. R. Gamble, I. Clark-Lewis, and M. A. Vadas. 1991. Interleukin-8 induces neutrophil transendothelial migration. Immunology 72: 65-72.
19. Fuller, H. R., N. T. Man, T. Lam, V. A. Shamanin, E. J. Androphy, and G. E. Morris. 2010. Valproate and bone loss: iTRAQ proteomics show that valproate reduces collagens and osteonectin in SMA cells. J. Proteome Res. 9: 4228-4233.
20. Kurup, S., T. J. Wijnhoven, G. J. Jenniskens, K. Kimata, H. Habuchi, J. P. Li, U. Lindahl, T. H. van Kuppevelt, and D. Spillmann. 2007. Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4. J. Biol. Chem. 282: 21032-21042.
21. Ten Dam, G. B., S. Kurup, E. M. van de Westerlo, E. M. Versteeg, U. Lindahl, D. Spillmann, and T. H. van Kuppevelt. 2006. 3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3. J. Biol. Chem. 281: 4654-4662.
22. Wu, N. Z., and A. L. Baldwin. 1992. Transient venular permeability increase and endothelial gap formation induced by histamine. Am. J. Physiol. 262: H1238-H1247.
23. Lacorre, D. A., E. S. Baekkevold, I. Garrido, P. Brandtzaeg, G. Haraldsen, F. Amalric, and J. P. Girard. 2004. Plasticity of endothelial cells: rapid dedifferentiation of freshly isolated high endothelial venule endothelial cells outside the lymphoid tissue microenvironment. Blood 103: 4164-4172.
24. Berndt, C., R. P. Casaroli-Marano, S. Vilaró, and M. Reina. 2001. Cloning and characterization of human syndecan-3. J. Cell. Biochem. 82: 246-259.
25. Patterson, A. M., L. Gardner, J. Shaw, G. David, E. Loreau, L. Aguilar, B. A. Ashton, and J. Middleton. 2005. Induction of a CXCL8 binding site on endothelial syndecan-3 in rheumatoid synovium. Arthritis Rheum. 52: 2331-2342.
26. Zimmermann, P., Z. Zhang, G. Degeest, E. Mortier, I. Leenaerts, C. Coomans, J. Schulz, F. N'Kuli, P. J. Courtoy, and G. David. 2005. Syndecan recycling [corrected] is controlled by syntenin-PIP2 interaction and Arf6. Dev. Cell 9: 377-388.
27. Spillmann, D., D. Witt, and U. Lindahl. 1998. Defining the interleukin-8-binding domain of heparan sulfate. J. Biol. Chem. 273: 15487-15493.
28. Uchimura, K., M. Morimoto-Tomita, A. Bistrup, J. Li, M. Lyon, J. Gallagher, Z. Werb, and S. D. Rosen. 2006. HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1. BMC Biochem. 7: 2.
29. Proudfoot, A. E., T. M. Handel, Z. Johnson, E. K. Lau, P. LiWang, I. Clark-Lewis, F. Borlat, T. N.Wells, and M. H. Kosco-Vilbois. 2003. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. USA 100: 1885-1890.
30. Hoogewerf, A. J., G. S. Kuschert, A. E. Proudfoot, F. Borlat, I. Clark-Lewis, C. A. Power, and T. N. Wells. 1997. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 36: 13570-13578.
31. Ali, S., H. Robertson, J. H. Wain, J. D. Isaacs, G. Malik, and J. A. Kirby. 2005. A non-glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein-3) antagonizes chemokine-mediated inflammation. J. Immunol. 175: 1257-1266.
32. Salanga, C. L., and T. M. Handel. 2011. Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function. Exp. Cell Res. 317: 590-601.
33. Carman, C. V. 2009. Mechanisms for transcellular diapedesis: probing and pathfinding by 'invadosome-like protrusions'. J. Cell Sci. 122: 3025-3035.
34. Wang, C. L., and L. M. Coluccio. 2010. New insights into the regulation of the actin cytoskeleton by tropomyosin. Int. Rev. Cell Mol. Biol. 281: 91-128.
35. Hashimoto, Y., D. J. Kim, and J. C. Adams. 2011. The roles of fascins in health and disease. J. Pathol. 224: 289-300.
36. Coluucio, L. M. 2008. Myosins: A Superfamiliy of Molecular Motors. Springer, Dorrecht, The Netherlands.
37. Fan, G. H., L. A. Lapierre, J. R. Goldenring, and A. Richmond. 2003. Differential regulation of CXCR2 trafficking by Rab GTPases. Blood 101: 2115-2124.
38. Cancelas, J. A., M. Jansen, and D. A. Williams. 2006. The role of chemokine activation of Rac GTPases in hematopoietic stem cell marrow homing, retention, and peripheral mobilization. Exp. Hematol. 34: 976-985.
39. Schraufstatter, I. U., J. Chung, and M. Burger. 2001. IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways. Am. J. Physiol. Lung Cell. Mol. Physiol. 280: L1094-L1103.